ArticleInternational journal of clinical and experimental pathology2019
Increased granulysin in the peripheral blood and tissues of patients with oral lichen planus.
Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral lichen planus (OLP) is a chronic inflammatory disease of unclear etiology and pathogenesis. Granulysin (GNLY) participates in various immune responses and mediates various skin diseases. However, its expression in OLP has not been reported. This study was to investigate whether there was an abnormal expression of GNLY in the peripheral blood and tissues of patients with OLP. Twenty patients with non-erosive OLP, twenty patients with erosive OLP, and twenty healthy controls were enrolled. The mRNA expression of GNLY in the peripheral blood and tissues was detected using RT-qPCR. The protein expression of GNLY in the peripheral blood plasma was measured using ELISA. The GNLY in tissues was investigated using immunohistochemistry. The mRNA and protein expression of GNLY in non-erosive and erosive OLP patients, when compared with the controls, were upregulated both in the peripheral blood and tissue. Also, in non-erosive and erosive OLP lesion tissues, there was a weak positive expression of GNLY in the lymphocyte membrane of the lamina propria layer and was less expressed in the epithelial layer. In normal mucosa, GNLY was hardly expressed. Furthermore, the immunohistochemical levels of GNLY in non-erosive and erosive OLP lesion were significantly higher than that in the normal oral mucosa. In conclusions, the expression of GNLY in the peripheral blood and tissues of OLP patients were significantly higher than controls, suggesting that there exists an abnormality in the expression of GNLY in OLP which might be involved in the pathogenesis of OLP.
Indexed as
Identifiers
31933981PMC6947134W3011861746What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.